...
首页> 外文期刊>Nuclear Science and Techniques >Influencing factors of radioiodine therapy in hyperthyroidism in adults
【24h】

Influencing factors of radioiodine therapy in hyperthyroidism in adults

机译:成人甲状腺功能亢进症放射碘治疗的影响因素

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The study was to evaluate factors affecting outcome of ~(131)I therapy in hyperthyroidism for optimizing the method. Data from 213 patients who received ~(131)I treatment from July 2003 to July 2005 in our department were retrospectively analyzed. Factors possibly contributing to the outcome of the ~(131)I therapy were analyzed, including gender, age, history of antithyroid drug, thyroid volume, duration of disease and radioactive iodine uptake rate. Multivari-ate analysis was done. The rates of euthyroidism and hypothyroidism were 69% and 8.5%, respectively, after one time ~(131)I therapy. Multivariate analysis of the patients showed no statistically significant factors affecting the outcome of ~(131)I therapy. The study showed that ~(131)I dose can be directly calculated, and this simplifies the dose-determined method and individualizes the therapy.
机译:该研究旨在评估影响甲亢中〜(131)I治疗效果的因素,以优化该方法。回顾性分析了我科2003年7月至2005年7月收治的〜(131)I治疗的213例患者的数据。分析了可能影响〜(131)I治疗结果的因素,包括性别,年龄,抗甲状腺药物史,甲状腺容量,疾病持续时间和放射性碘吸收率。进行了多元分析。 〜(131)I治疗一次后,甲状腺功能正常和甲状腺功能低下的发生率分别为69%和8.5%。对患者的多变量分析显示,没有统计学上显着的因素影响〜(131)I治疗的结果。研究表明〜(131)I剂量可以直接计算,从而简化了剂量确定的方法,并使治疗个性化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号